Skip to main content

Table 1 Analytic validation study of cell lines

From: A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study

Cell Lines

Description

ER/PR/HER2 Status

Average PID score/ Average ST.DEV.

MCF7

Human epithelial breast mammary gland cells, positive for adenocarcinoma

+/+/−

11.5/0.6

T47D

Human epithelial breast mammary gland cells, positive for ductal carcinoma

+/+/−

40.6/2.9

HTB21

Human epithelial breast mammary gland cells, positive for adenocarcinoma

+/+/−

115.2/6.5

CRL1500

Human epithelial breast mammary gland cells, positive for ductal carcinoma

+/+/+

299.5/15.5

CRL1897

Human epithelial breast mammary gland cells, positive for ductal carcinoma

−/−/+

859.3/18.1

KPL4

Human epithelial breast mammary gland cells, positive for ductal carcinoma

−/−/++

1258.5/52.6

  1. ER: estrogen receptor status, PR: progesterone receptor status, St.Dev.: standard deviation, (+): positive, (−): negative, (++): highly positive